These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26298505)

  • 21. Do guidelines recommending pharmacogenetic testing of psychiatric patients affect treatment costs and the use of healthcare services?
    Herbild L; Bech M; Gyrd-Hansen D; Christensen M; Werge T; Nielsen KA
    Scand J Public Health; 2011 Mar; 39(2):147-55. PubMed ID: 21257648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.
    Drozda K; Müller DJ; Bishop JR
    Pharmacotherapy; 2014 Feb; 34(2):166-84. PubMed ID: 24523097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
    Stanek EJ; Sanders CL; Taber KA; Khalid M; Patel A; Verbrugge RR; Agatep BC; Aubert RE; Epstein RS; Frueh FW
    Clin Pharmacol Ther; 2012 Mar; 91(3):450-8. PubMed ID: 22278335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions.
    Haga SB; O'Daniel JM; Tindall GM; Lipkus IR; Agans R
    Genet Med; 2011 Aug; 13(8):723-8. PubMed ID: 21633294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current applications of clinical genetic testing for psychiatric practice.
    Mrazek DA
    Minn Med; 2007 Jan; 90(1):42-3. PubMed ID: 17305105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
    Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
    Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacogenetic Testing: Why Is It So Disappointing?
    Limandri BJ
    J Psychosoc Nurs Ment Health Serv; 2019 Apr; 57(4):9-12. PubMed ID: 30933297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential utility of pharmacogenetic testing in psychiatry.
    Gardner KR; Brennan FX; Scott R; Lombard J
    Psychiatry J; 2014; 2014():730956. PubMed ID: 25587529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is needed to incorporate clinical pharmacogenetic tests into the practice of psychopharmacotherapy?
    de Leon J; Spina E
    Expert Rev Clin Pharmacol; 2016; 9(3):351-4. PubMed ID: 26580456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings.
    Fagerness J; Fonseca E; Hess GP; Scott R; Gardner KR; Koffler M; Fava M; Perlis R; Brennan FX; Lombard J
    Am J Manag Care; 2014 May; 20(5):e146-56. PubMed ID: 25326929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Impact of Pharmacogenetic-Guided Treatment for Patients Exhibiting Neuropsychiatric Disorders: A Randomized Controlled Trial.
    Olson MC; Maciel A; Gariepy JF; Cullors A; Saldivar JS; Taylor D; Centeno J; Garces JA; Vaishnavi S
    Prim Care Companion CNS Disord; 2017 Mar; 19(2):. PubMed ID: 28314093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early adoption of pharmacogenetic testing for veterans prescribed psychotropic medications.
    Hull LE; Chanfreau-Coffinier C; Tuteja S; Berlowitz D; Lehmann LS; Oslin DW; Pyne JM; DuVall SL; Lynch JA
    Pharmacogenomics; 2019 Jul; 20(11):781-789. PubMed ID: 31393222
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacogenetic testing in the United Kingdom genetics and immunogenetics laboratories.
    Higgs J; Gambhir N; Ramsden SC; Poulton K; Newman WG
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):121-5. PubMed ID: 20039783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of pharmacogenetics in psychiatry].
    Skrętkowicz J; Barańska M; Rychlik-Sych M
    Wiad Lek; 2013; 66(2 Pt 2):185-91. PubMed ID: 25775815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community pharmacists' experience with pharmacogenetic testing.
    Moaddeb J; Mills R; Haga SB
    J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychiatrists' attitudes regarding genetic testing and patient safeguards: a preliminary study.
    Hoop JG; Roberts LW; Green Hammond KA; Cox NJ
    Genet Test; 2008 Jun; 12(2):245-52. PubMed ID: 18452395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [General practitioners' training in psychiatry and prescription of psychotropic drugs. 1. Education, attitudes and extent of prescribing].
    Holm M
    Ugeskr Laeger; 1990 Aug; 152(32):2285-7. PubMed ID: 2399613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicians' opinion for 'new' genetic testing in Japan.
    Ohata T; Tsuchiya A; Watanabe M; Sumida T; Takada F
    J Hum Genet; 2009 Apr; 54(4):203-8. PubMed ID: 19300458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research.
    Daud ANA; Bergsma EL; Bergman JEH; De Walle HEK; Kerstjens-Frederikse WS; Bijker BJ; Hak E; Wilffert B
    BMC Pregnancy Childbirth; 2017 Apr; 17(1):120. PubMed ID: 28410576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery.
    Powell G; Holmes EA; Plumpton CO; Ring A; Baker GA; Jacoby A; Pirmohamed M; Marson AG; Hughes DA
    Br J Clin Pharmacol; 2015 Nov; 80(5):1149-59. PubMed ID: 26138622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.